Stage III Fallopian Tube Cancer AJCC v7

9 clinical trials · Condition

Sort:Newest first Oldest first

◉ Watch Stage III Fallopian Tube Cancer AJCC v7

Record	Firm	Date
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02713386)	NRG Oncology	2016-11-14
Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer (NCT03902379)	Rutgers, The State University of New Jersey	2016-07-27
Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur) (NCT02726997)	M.D. Anderson Cancer Center	2016-07-06
Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT02520154)	M.D. Anderson Cancer Center	2016-07-05
Talazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02316834)	M.D. Anderson Cancer Center	2015-06-02
Epacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02042430)	National Cancer Institute (NCI)	2014-08-25
Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer (NCT01970722)	City of Hope Medical Center	2014-05-19
Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT01504126)	M.D. Anderson Cancer Center	2012-03-09

Track Stage III Fallopian Tube Cancer AJCC v7 automatically

Every clearance here is in the API, with alerts when new ones post.